Copyright
©The Author(s) 2022.
World J Hepatol. Feb 27, 2022; 14(2): 319-337
Published online Feb 27, 2022. doi: 10.4254/wjh.v14.i2.319
Published online Feb 27, 2022. doi: 10.4254/wjh.v14.i2.319
Figure 2 Non-alcoholic fatty liver disease risk factor in inflammatory bowel disease.
Created with Biorender. IBD: Inflammatory bowel disease; NAFL: Nonalcoholic fatty liver; NASH: Nonalcoholic steatohepatitis; BMI: Body mass index; DM2: Diabetes mellitus 2; IR: Insulin resistance; DILI: Drug induced liver injury.
- Citation: Núñez F P, Castro F, Mezzano G, Quera R, Diaz D, Castro L. Hepatobiliary manifestations in inflammatory bowel disease: A practical approach. World J Hepatol 2022; 14(2): 319-337
- URL: https://www.wjgnet.com/1948-5182/full/v14/i2/319.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i2.319